Teriparatide (1-34) vs. parathyroid hormone (1-84) in women with severe postmenopausal osteoporosis: a randomized, head-to-head study.

Research output: Contribution to conferenceOther

Original languageEnglish
PagesA09001551.-A09001551.
Number of pages0
Publication statusPublished - 2009

Cite this